Uzbekistan

Kazakh study finds antibiotic resistance in H. pylori

Kazakh study finds antibiotic resistance in H. pylori
Kazakh study finds antibiotic resistance in H. pylori / Photo: Personal archive..

Tashkent, Uzbekistan (UzDaily.uz) — A study by researchers in Kazakhstan found that Helicobacter pylori bacteria showed resistance to amoxicillin and metronidazole at rates of 20.98% and 20.58%, respectively, raising questions about the effectiveness of commonly used treatments.

The findings were presented on 20 November at an international conference on combating antimicrobial resistance in Astana. The research highlights the importance of accounting for local antibiotic resistance patterns when treating the infection in Central Asian countries.

The study, entitled "Local Antibiotic Resistance of H. pylori as the Basis for Rational Antimicrobial Therapy in Kazakhstan", was presented by specialists from the research laboratory of the Pyotr Pospelov Karaganda Medical University.

The research was conducted under grant IRN AP19575049 for 2023–2025. It aimed to assess H. pylori's susceptibility to antibiotics, identify genetic mechanisms of resistance and examine factors affecting treatment outcomes.

Speaking at the conference, a researcher noted that Helicobacter pylori is a concern not only because it causes chronic gastritis and peptic ulcers. Long-term infection with the bacterium is also an established risk factor for stomach cancer.

The International Agency for Research on Cancer (IARC) classifies H. pylori infection as a Group 1 carcinogen. However, infection does not mean that every person carrying the bacterium will develop cancer.

Antibiotics showing resistance

The study examined 110 H. pylori isolates. The E-test method was used to assess the bacteria's susceptibility to antimicrobial drugs.

According to the findings, resistance to amoxicillin stood at 20.98%, while resistance to metronidazole was 20.58%.

Resistance rates for clarithromycin, tetracycline and rifampicin were 9.8% each. The rate for levofloxacin was 4.9%.

The researchers described resistance to amoxicillin and metronidazole as critical because both rates exceeded 20%.

The authors said the findings called for a review of empirical treatment approaches, in which antibiotics are prescribed without first testing the susceptibility of the specific pathogen.

They proposed adapting clinical protocols to local data and considering alternative treatment regimens.

Levofloxacin had the lowest resistance rate among the drugs studied, at 4.9%. The researchers suggested that this finding could be taken into account when selecting second-line treatment regimens.

However, the results of a single study do not mean that the drug should be prescribed to all patients. Treatment decisions must take account of current clinical guidelines, contraindications and individual patient circumstances.

Genetic research confirms links between mutations and resistance

In addition to testing antibiotic susceptibility, the researchers conducted molecular genetic analysis using polymerase chain reaction (PCR).

They examined mutations in genes associated with resistance to specific drugs, including PBP1, 23S rRNA, rdxA and 16S rRNA.

The study found statistically significant associations between certain genetic changes and phenotypic resistance in H. pylori.

Significant results were reported for mutations associated with resistance to amoxicillin, clarithromycin and metronidazole.

The authors said molecular tests could help identify resistant strains more quickly and assist doctors in selecting more appropriate treatment regimens.

Risk of treatment failure was 2.43 times higher

The researchers also examined genetic factors that could affect the effectiveness of eradication therapy, which aims to eliminate Helicobacter pylori.

According to the findings, the presence of the IceA2 genotype was associated with an increased risk of treatment failure.

Patients with this genotype had approximately 2.43 times higher odds of unsuccessful eradication (odds ratio: 2.429; p = 0.005).

The researchers said this genetic marker could be considered an additional factor when planning treatment.

Review of prescriptions identifies problems with treatment regimens

The study also included a retrospective analysis of 48 medical records from patients at a clinic in Karaganda in 2023.

According to the results, dual antibiotic therapy was recorded in 22.9% of cases, metronidazole monotherapy in 25.7%, treatment with proton pump inhibitors alone, without antibiotics, in 39.6%, and bismuth monotherapy in 21.6%.

The presenter clarified that the prescription categories overlapped, meaning their combined share exceeded 100%.

The researchers said the practices identified pointed to a need for stronger oversight of prescriptions and better compliance with clinical guidelines.

Proposed measures included revising empirical treatment approaches to reflect local resistance patterns, introducing molecular diagnostics and improving audits of clinical practice.

Why the findings matter for Uzbekistan

The study by Kazakh researchers highlights the importance of local antibiotic resistance data when selecting treatments for infections.

Helicobacter pylori susceptibility to antimicrobial drugs can vary between countries and regions. Treatment regimens that do not account for local epidemiological conditions may therefore be less effective.

For Uzbekistan, the findings are relevant to the development of laboratory diagnostics, research into local resistance patterns and efforts to improve the rational use of antibiotics.

However, resistance rates recorded in Kazakhstan cannot automatically be applied to Uzbekistan's population. Local studies are needed to assess the prevalence of resistant strains.

The research demonstrates how combining laboratory antibiotic susceptibility testing, molecular genetic methods and analysis of clinical practice can help improve treatment effectiveness.

Kamila Fayzieva
Kamila Fayzieva

Kamila Fayzieva is a Researcher & Analyst specializing in Climate, Economy & Fintech Systems. She is a contributor to UzDaily.